PULMONARY FIBROSIS
Clinical trials for PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to improve lung fibrosis treatment
Disease control Not yet recruitingThis study tests whether adding the drug nerandomilast to the standard treatment mycophenolate is safe and tolerable for people with pulmonary fibrosis (lung scarring). About 120 adults with various types of lung fibrosis will take the combination for 4 months. The main goal is t…
Matched conditions: PULMONARY FIBROSIS
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New drug shows promise for lung scarring in Long-Term trial
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called admilparant in people with pulmonary fibrosis (lung scarring). About 2,277 adults who finished earlier studies will take part. The goal is to see if the drug is safe to take over a longer period, not to cure the disease.
Matched conditions: PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Breakthrough scan could replace needle biopsies for fibrosis
Diagnosis Not yet recruitingThis study tests a new type of PET scan that uses a special tracer to find fibrosis (scarring) in organs like the lungs. It aims to see if this scan can diagnose fibrosis more safely and accurately than current methods, which often require invasive biopsies. The study will involv…
Matched conditions: PULMONARY FIBROSIS
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated May 26, 2026 11:42 UTC